Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Treasury Shares (2020 - 2025)

Relay Therapeutics (RLAY) has disclosed Treasury Shares for 6 consecutive years, with $2.4 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares fell 58.39% to $2.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Dec 2025, down 58.39% year-over-year, with the annual reading at $2.4 million for FY2025, 58.39% down from the prior year.
  • Treasury Shares for Q4 2025 was $2.4 million at Relay Therapeutics, down from $5.8 million in the prior quarter.
  • The five-year high for Treasury Shares was $5.8 million in Q4 2024, with the low at $691205.0 in Q4 2021.
  • Average Treasury Shares over 5 years is $2.7 million, with a median of $2.4 million recorded in 2025.
  • The sharpest move saw Treasury Shares skyrocketed 718.1% in 2021, then tumbled 58.39% in 2025.
  • Over 5 years, Treasury Shares stood at $691205.0 in 2021, then soared by 126.67% to $1.6 million in 2022, then surged by 90.98% to $3.0 million in 2023, then soared by 94.12% to $5.8 million in 2024, then crashed by 58.39% to $2.4 million in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $2.4 million, $5.8 million, and $3.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.